Llor C - Search Results

1

Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care.

Llor C, Hernández S, Ribas A, Alvarez C, Cots JM, Bayona C, González I, Miravitlles M; BRAMOX Study Group. Llor C, et al. Int J Chron Obstruct Pulmon Dis. 2009;4:45-53. Epub 2009 Apr 15. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 19436696 Free PMC article. Clinical Trial.

2

[Use of the Internet in a multicenter study of chronic obstructive pulmonary disease in primary care. Pilot phase of the EFEMAP study].

Miravitlles M, Llor C, Naberan K, Cots JM; Estudio EFEMAP. Miravitlles M, et al. Among authors: llor c. Arch Bronconeumol. 2002 Sep;38(9):427-30. doi: 10.1016/s0300-2896(02)75256-3. Arch Bronconeumol. 2002. PMID: 12237014 Spanish.

3

Spanish primary healthcare physicians' knowledge of resistance of respiratory germs and antimicrobial treatment in acute bronchitis.

Llor C, Bayona C. Llor C, et al. Eur J Gen Pract. 2004 Sep;10(3):88-92. doi: 10.3109/13814780409044541. Eur J Gen Pract. 2004. PMID: 15534572 Free article.

4

Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.

Llor C, Naberan K, Cots JM, Molina J, Miravitlles M. Llor C, et al. Int J Clin Pract. 2004 Oct;58(10):937-44. doi: 10.1111/j.1368-5031.2004.00293.x. Int J Clin Pract. 2004. PMID: 15587773

5

Over the counter antibacterials in southern Europe.

Llor C, Reig R, Hernandez S, Sugrañes J. Llor C, et al. Scand J Infect Dis. 2005;37(5):399-400. doi: 10.1080/00365540510034509. Scand J Infect Dis. 2005. PMID: 16051586 No abstract available.

6

[Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease].

Llor C, Naberan K, Cots JM, Molina J, Ros F, Miravitlles M; Estudio EFEMAP. Llor C, et al. Arch Bronconeumol. 2006 Apr;42(4):175-82. doi: 10.1016/s1579-2129(06)60439-4. Arch Bronconeumol. 2006. PMID: 16735014 Spanish.

7

Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.

Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, Llor C; EVAN Study Group. Vila-Córcoles A, et al. Among authors: llor c. Clin Infect Dis. 2006 Oct 1;43(7):860-8. doi: 10.1086/507340. Epub 2006 Aug 21. Clin Infect Dis. 2006. PMID: 16941367 Clinical Trial.

8

Effect of intervention promoting a reduction in antibiotic prescribing by improvement of diagnostic procedures: a prospective, before and after study in general practice.

Bjerrum L, Cots JM, Llor C, Molist N, Munck A. Bjerrum L, et al. Among authors: llor c. Eur J Clin Pharmacol. 2006 Nov;62(11):913-8. doi: 10.1007/s00228-006-0187-y. Epub 2006 Sep 12. Eur J Clin Pharmacol. 2006. PMID: 16967300

9

More evidence is required for short-term treatment of exacerbations of chronic obstructive pulmonary disease: 3 days or no antibiotic at all?

Llor C, Miravitlles M. Llor C, et al. Clin Microbiol Infect. 2007 Jul;13(7):748-9. doi: 10.1111/j.1469-0691.2007.01754.x. Clin Microbiol Infect. 2007. PMID: 17501972 Free article. No abstract available.

10

Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.

Llor C, Molina J, Naberan K, Cots JM, Ros F, Miravitlles M; EVOCA study group. Llor C, et al. Int J Clin Pract. 2008 Apr;62(4):585-92. doi: 10.1111/j.1742-1241.2008.01707.x. Epub 2008 Feb 7. Int J Clin Pract. 2008. PMID: 18266710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters